Accelerate your recruitment timeline.
Cosign AI enables investigators and clinical sites to identify eligible patients in real time at the point of care. Our technology surfaces the right candidates for the right trials - effortlessly, accurately, and without disrupting clinical workflows.
Contact Us
The recruitment crisis
It has been estimated that over 80% of clinical trials are behind schedule1 and sponsors lose $15m in lost revenue per month due to trial delays.2
Breakthrough science deserves breakthrough timelines. Yet clinical development is often defined by delay. Burdensome manual work, missed patients, high screen failures leads to slow recruitment. Every month lost means patients wait, and costs balloon.
Every missed patient is a missed opportunity; for science, for sponsors, and for patients.
1 Huang GD, Bull J, McKee KJ, et al. Clinical trials recruitment planning: A proposed framework from the Clinical Trials Transformation Initiative. Contemp Clin Trials. 2018;66:74-79. doi:10.1016/j.cct.2018.01.003.
2 Smith ZP, DiMasi JA, Getz KA. New Estimates on the Cost of a Delay Day in Drug Development. Ther Innov Regul Sci. 2024 Sep;58(5):855-862
Finish ahead of schedule
Cosign AI enables investigators and research sites to identify eligible clinical trial patients in real time at the point of care. All while seamlessly integrating into the workflow of busy clinics.
Patients screened each month
Accuracy
